Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,877 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer.
Niethammer AG, Lubenau H, Mikus G, Knebel P, Hohmann N, Leowardi C, Beckhove P, Akhisaroglu M, Ge Y, Springer M, Grenacher L, Buchler MW, Koch M, Weitz J, Haefeli WE, Schmitz-Winnenthal FH. Niethammer AG, et al. Among authors: koch m. BMC Cancer. 2012 Aug 20;12:361. doi: 10.1186/1471-2407-12-361. BMC Cancer. 2012. PMID: 22906006 Free PMC article. Clinical Trial.
Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer.
Timke C, Winnenthal HS, Klug F, Roeder FF, Bonertz A, Reissfelder C, Rochet N, Koch M, Tjaden C, Buechler MW, Debus J, Werner J, Beckhove P, Weitz J, Huber PE. Timke C, et al. Among authors: koch m. BMC Cancer. 2011 Apr 13;11:134. doi: 10.1186/1471-2407-11-134. BMC Cancer. 2011. PMID: 21489291 Free PMC article. Clinical Trial.
A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancer.
Reissfelder C, Timke C, Schmitz-Winnenthal H, Rahbari NN, Koch M, Klug F, Roeder F, Edler L, Debus J, Büchler MW, Beckhove P, Huber PE, Weitz J. Reissfelder C, et al. Among authors: koch m. BMC Cancer. 2011 Sep 30;11:419. doi: 10.1186/1471-2407-11-419. BMC Cancer. 2011. PMID: 21961577 Free PMC article. Clinical Trial.
AB0 blood group and prognosis in patients with pancreatic cancer.
Rahbari NN, Bork U, Hinz U, Leo A, Kirchberg J, Koch M, Büchler MW, Weitz J. Rahbari NN, et al. Among authors: koch m. BMC Cancer. 2012 Jul 28;12:319. doi: 10.1186/1471-2407-12-319. BMC Cancer. 2012. PMID: 22838843 Free PMC article.
Potential target antigens for immunotherapy in human pancreatic cancer.
Schmitz-Winnenthal FH, Galindo-Escobedo LV, Rimoldi D, Geng W, Romero P, Koch M, Weitz J, Krempien R, Niethammer AG, Beckhove P, Buchler MW, Z'graggen K. Schmitz-Winnenthal FH, et al. Among authors: koch m. Cancer Lett. 2007 Jul 18;252(2):290-8. doi: 10.1016/j.canlet.2007.01.003. Epub 2007 Feb 22. Cancer Lett. 2007. PMID: 17320278
3,877 results